Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

11.5K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils03:03

Amyloid Fibrils

6.2K
6.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Neural Regulation01:37

Neural Regulation

43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lewy bodies are surrounded by granulovacuolar degeneration bodies in dementia with Lewy bodies.

Brain pathology (Zurich, Switzerland)·2026
Same author

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

The Journal of antimicrobial chemotherapy·2026
Same author

The prevalence of Lewy body pathology across nine international community-based cohorts.

Brain : a journal of neurology·2026
Same author

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Clinical pharmacology and therapeutics·2026
Same author

Evaluating the Sexual Quality of Life of Kidney Stone Formers: A Multicentric Cross-Sectional Study.

Journal of endourology·2026
Same author

High vulnerability of medial prefrontal pyramidal neurons in post-stroke, vascular, Alzheimer's disease, and aging-related dementias.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: Dec 27, 2025

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.3K

Relationship Between Tau, β Amyloid and α-Synuclein Pathologies.

Lauren Walker1, Johannes Attems2

  • 1Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. Lauren.walker1@ncl.ac.uk.

Advances in Experimental Medicine and Biology
|February 26, 2020
PubMed
Summary

Multiple co-existing brain lesions in elderly individuals, including those with dementia, impact neurodegenerative disease progression. Understanding these protein aggregate interactions is crucial for predicting clinical outcomes in dementia.

Keywords:
Mixed dementiaMixed pathologyTauα-synucleinβ amyloid

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.9K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.1K

Related Experiment Videos

Last Updated: Dec 27, 2025

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.3K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.9K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.1K

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Multiple pathological lesions frequently coexist in elderly brains, affecting both demented and non-demented individuals.
  • Interactions between these lesions occur at the molecular level, contributing to cumulative brain damage.
  • The presence of multiple protein aggregates is increasingly recognized as a significant factor in neurodegenerative diseases.

Purpose of the Study:

  • To discuss the impact of multiple pathological lesions on the pathological and clinical phenotypes of neurodegenerative disorders.
  • To explore the implications of co-existing lesions for dementia progression.
  • To highlight the role of molecular interactions in disease manifestation.

Main Methods:

  • Review of existing literature on neuropathology in aging and dementia.
  • Analysis of studies investigating co-pathologies in neurodegenerative diseases.
  • Discussion of molecular mechanisms underlying lesion interactions.

Main Results:

  • Evidence suggests that the interplay of multiple lesions significantly influences the presentation and severity of neurodegenerative diseases.
  • Cumulative effects of diverse pathological insults contribute to brain damage.
  • The combination of lesions, rather than single pathologies, may better predict clinical outcomes.

Conclusions:

  • The co-existence of multiple pathological lesions is a critical determinant of the clinical course in neurodegenerative disorders associated with dementia.
  • Understanding these complex interactions is essential for accurate diagnosis and prognosis.
  • Further research into the molecular basis of co-pathology is warranted to develop targeted therapies.